USPTO trademark

KAMNUVY

RegisteredUSPTOWord markClass 5

"KAMNUVY" is a word mark owned by Glaxo Group Limited, filed at the USPTO on September 3, 2025. It is registered and covers class 5 (Pharmaceuticals).

View Glaxo Group Limited portfolio Get this data via the API

Data current as of February 11, 2026Official USPTO record

As filed with the USPTO

Status: Registered; Since February 10, 2026
Filed: September 3, 2025
Registered: February 10, 2026
Priority date: August 22, 2025; Claimed from United Kingdom
Application no.: 99371415
Registration no.: 8137359
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 1 class

Ownership

Who owns KAMNUVY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Glaxo Group Limited

Stevenage, United Kingdom

19,383 trademarks in the portfolioView company

Representative

Elizabeth K. Rucki

GSK

Goods and services

What the mark covers

The products and services KAMNUVY is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

History

What has happened so far

Steps recorded by the USPTO, newest first.

February 10, 2026Notice of registration confirmation emailed
February 10, 2026Registered-principal register
December 23, 2025Official gazette publication confirmation e-mailed
December 23, 2025Published for opposition
December 17, 2025Notification of notice of publication e-mailed
November 25, 2025Approved for pub - principal register
November 21, 2025Teas/email correspondence entered
November 21, 2025Correspondence received in law office
November 21, 2025Teas response to suspension inquiry received
October 24, 2025Notification of letter of suspension e-mailed

6 earlier steps on the official record.

FAQ

About KAMNUVY

Who owns the trademark "KAMNUVY"?

The USPTO trademark "KAMNUVY" (application 99371415) is owned by Glaxo Group Limited.

What is the status of "KAMNUVY"?

Its status at the USPTO is: registered.

When was "KAMNUVY" registered?

It was registered on February 10, 2026.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull KAMNUVY and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2b20-d6ee-73ff-97df-160ef4ff196e
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2b20-d6ee-73ff-97df-160ef4ff196e",
  "object": "trademark",
  "mark_text": "KAMNUVY",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "99371415",
  "filing_date": "2025-09-03",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Glaxo Group Limited",
      "entity_id": "ent_019eb6f6-4cb9-77ae-916f-63b3231a6d3d"
    }
  ]
}